Published in Am J Manag Care on November 01, 2007
Metabolic syndrome in people with schizophrenia: a review. World Psychiatry (2009) 1.96
'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol (2012) 1.28
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas (2014) 1.17
A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. PLoS One (2011) 0.99
Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography. Biol Psychiatry (2010) 0.97
Subthreshold bipolarity: diagnostic issues and challenges. Bipolar Disord (2011) 0.94
Gender differences in the association between body mass index and psychopathology. CNS Spectr (2009) 0.93
Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis. BMC Med Genomics (2013) 0.91
Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone. Eur Arch Psychiatry Clin Neurosci (2010) 0.91
STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications. BMC Psychiatry (2013) 0.89
Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav Brain Res (2011) 0.88
Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration. BMC Psychiatry (2009) 0.86
Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatry (2011) 0.84
Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. Neuroendocrinology (2013) 0.83
Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One (2011) 0.82
Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia. Biol Res Nurs (2010) 0.80
Development of an integrated psychosocial treatment to address the medical burden associated with bipolar disorder. J Psychiatr Pract (2011) 0.80
Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. Schizophr Res Treatment (2010) 0.79
Physical performance and disability in schizophrenia. Schizophr Res Cogn (2014) 0.79
Weight changes in Portuguese patients with depression: which factors are involved? Nutr J (2014) 0.79
Emerging role of sertindole in the management of schizophrenia. Neuropsychiatr Dis Treat (2010) 0.79
Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus. Bipolar Disord (2010) 0.79
Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis. CNS Drugs (2013) 0.78
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine. J Psychiatr Pract (2009) 0.78
Systems Nutrigenomics Reveals Brain Gene Networks Linking Metabolic and Brain Disorders. EBioMedicine (2016) 0.78
System-based proteomic and metabonomic analysis of the Df(16)A(+/-) mouse identifies potential miR-185 targets and molecular pathway alterations. Mol Psychiatry (2016) 0.77
Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia. Behav Brain Funct (2014) 0.77
Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with Controls. Comput Struct Biotechnol J (2016) 0.76
Sequential behavioral treatment of smoking and weight control in bipolar disorder. Transl Behav Med (2012) 0.76
Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study. PLoS One (2015) 0.75
Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review. J Gen Intern Med (2016) 0.75
Metabolic syndrome in patients with severe mental illness in Gorgan. J Nat Sci Biol Med (2016) 0.75
Gelidium elegans Regulates the AMPK-PRDM16-UCP-1 Pathway and Has a Synergistic Effect with Orlistat on Obesity-Associated Features in Mice Fed a High-Fat Diet. Nutrients (2017) 0.75
Systems Pharmacology Based Study of the Molecular Mechanism of SiNiSan Formula for Application in Nervous and Mental Diseases. Evid Based Complement Alternat Med (2016) 0.75
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. Transl Psychiatry (2016) 0.75
Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia? Curr Psychiatr (2016) 0.75
Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia. Can J Psychiatry (2016) 0.75
The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia. Neuropsychiatr Dis Treat (2014) 0.75
Metabolic syndrome in patients with severe mental illness undergoing psychiatric rehabilitation receiving high dose antipsychotic medication. Indian J Psychol Med (2012) 0.75